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Background: There is now a clear trend with increased usage of cementless femoral stems for all ages and
most patients. As the number of total hip arthroplasties (THAs) performed annually continues to increase
with expanding indications for THA and demands for improved quality of life, so will the prevalence of
THA in the elderly and aging populations. This is worrisome as the risk of complications with cementless
femoral stems increases in elderly patients and those with poor bone quality. The purpose of this study is
to analyze the available data from comparative studies to determine whether cementless femoral stems
are overused and whether cemented stems warrant increased consideration.
Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines,
searches were performed to ﬁnd original studies comparing cementless and cemented femoral stems;
large population registry studies and reports were also included.
Results: This systematic review documents that older patients with cementless ﬁxation increase the risk of
revision, there is no clear ﬁxation advantage in midaged patients, and younger patients fare better with
cementless ﬁxation. Complications after THA create burdens on the health care system and on patients.
Conclusions: Using evidence-based data should be better guidance in selecting the most reliable
implants for THA. Although cementless femoral ﬁxation for THA has evolved to the “new standard,” it has
not been proven to be the “gold standard” for all patients.
© 2016 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction and background
Cementless femoral component use in primary total hip arthro-
plasty (THA) has increased substantially over the last 3 decades. It
was recently reported that in 2012, 93% of THAs in the Orthopedic
ResearchNetwork, a group of 174 hospitals in the United States, were
cementless [1]. With the adoption of press-ﬁt cementless femoral
implants, the incidence of early complications, especially femoralclosed potential or pertinent
ent, either direct or indirect,
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c-nd/4.0/).periprosthetic fracture, resulting in early revision continues to
increase [2,3]. Other known risk factors for periprosthetic fracture
include elderly patients, female gender, osteoporotic bone, and
metabolic bone disease [2-7].
It is clear that the number of THAs performed annually will
continue to increase because of aging populations with improve-
ment in life expectancy [2,8]. The aging of the baby boomer gen-
eration along with expanding indications for THA and demands for
improved quality of life, as well as policies to improve access to
THA, all ensure that the numbers of THA will continue to grow
[2,8,9]. Adding the effects of increased use of cementless femoral
stems to the growing prevalence of elderly patients and patients
with poor bone quality, the absolute number and relative risk of
periprosthetic fractures are likely to increase both intraoperatively
and postoperatively [10]. In 2013, periprosthetic fracture was one
of the most common complications globally of primary THA,
accounting for 6% of all THA revisions [11]. Revision of THA due tociation of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-
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complications, deep periprosthetic infection, decreased function,
increased morbidity andmortality, and signiﬁcant health care costs
[8,12].
Cemented femoral stems are not without their own risks such as
bone cement implantation syndrome, fat embolism syndrome, and
the difﬁculty of removing cement during explantation or revision
surgery. Bone cement implantation syndrome is characterized by
hypoxia, hypotension, or both and/or the unexpected loss of con-
sciousness and is most commonly associated with cemented THA
[13]. Cemented femoral stems also have certain beneﬁts; they have
been shown to minimize the risk of early complications, as well as
having excellent long-term survivorship, and are cost-effective
implants [14,15].
There is no clear and compelling body of evidence we are aware
of to support the routine use of cementless femoral component
ﬁxation over cemented stems in all patients, especially elderly
patients or those with poor-quality bone for primary THA. How-
ever, despite this, cementless femoral stem use prevails in much of
North America and is increasing globally in that patient population
[16]. The purpose of this study is to analyze the available data from
comparative studies evaluating cementless and cemented femoral
components in primary THAwith a focus on rates of complications,
survivorship, and risk factors for periprosthetic fracture.
Material and methods
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses guidelines were used to conduct this review [17,18].
Original studies in the English language that involved THA inwhich
cementless femoral stems were compared to cemented femoral
stems are included. Large population registry studies and reports
are also included. Review articles, case series, and case reports were
excluded.
The PubMed database was interrogated for articles from January
2000 to April 2015, using 4 search strings: (1) “cemented femoral
stems” and “cementless femoral stems,” (2) “meta analysis” and
(“femoral” or “femur”) and (“stem” or “component”), (3) “primary”
and “total hip” and (“arthroplasty” or “replacement”) and
(“cement” or “cementless” or “press-ﬁt”) and “femoral” and
(“component” or “stem”), and (4) “registry” and (“cemented” or
“cementless”) and “total hip” and (“arthroplasty” or “replace-
ment”). In addition, other articles were sourced from the reference
lists of meta-analyses and reference lists of included articles. In
total, 517 records were found and screened (Fig. 1). First, 382
records were excluded based on titles and abstracts and an addi-
tional 85 full-text articles after further review (Supplementary
Material). This article is composed of the remaining 50 articles:
26 as background/discussion material, 3 meta-analyses/systematic
reviews, 15 large population data (arthroplasty registries and
insurance databases), and 6 included in qualitative analyses.
Results
Results are in 3 distinct categories: meta-analysis and system-
atic reviews, large population data, and qualitative analysis of pri-
mary research. This is done because the probability for bias is
different in each category. Meta-analyses and systematic reviews
should have less bias, especially when conducted on randomized
controlled trails (RCTs), than either of the other categories. Large
population data may be biased because of the homogeneity of the
population itself. Primary research may be biased because of the
homogeneity of the population and the homogeneity of surgical
technique and surgical experience. Using these categories seems to
be a logical way to present data that are not standardized withregard to reporting technique or variables being reported. Data are
summarized in Table 1.
Meta-analysis and systematic reviews
There are 2 meta-analyses/systematic reviews concerning the
difference between cemented and cementless ﬁxations in THA that
do not speciﬁcally discuss femoral components [19,20]. Owing to
the nature of published data, it is not possible for these reviews to
draw conclusions about the performance of individual femoral
stem designs nor is it possible to draw conclusions about the causes
of THA failure.
Morshed et al. [19] examined failure of THA deﬁned as (1)
revision of either or both components or (2) revision of a speciﬁc
component and found no advantage for either cemented ﬁxation or
cementless ﬁxation in their meta-analysis. Subgroup analysis by
patient age found cemented ﬁxation to have superior survival in
studies containing patients of all ages but not in studies focused on
younger patients (aged 55 years; P ¼ .004) [19]. They found that
neither the size of the study population nor the level of evidence of
the study inﬂuences revision rates [19]. The authors looked further
into the possible connection between year of publication and sur-
vival and found that cementless ﬁxation showed a relative supe-
riority over time, suggesting improvements in that technique and
general cementless implant design [19].
Abdulkarim et al. [20] performed a meta-analysis of RCTs that
compared cemented and cementless ﬁxations in THA; the ﬁxation
method for both the femoral stem and the acetabular cup was the
Table 1
Data summary table.
Reference Classiﬁcation Relevant outcomes
Morshed et al. [19] Meta-analysis
Primary THA
Subgroup analysis by age
 Cemented ﬁxation in THA exhibits superior implant survival for all
ages when patients are not stratiﬁed by age (P ¼ .004).
 Neither ﬁxation in THA has superior implant survival for studies in
which all patients are of age 55 years.
Abdulkarim et al. [20] Meta-analysis
Primary THA
Randomized controlled trials only
 Neither ﬁxation in THA has superior implant survival measured by
revision rate (P ¼ .14, n ¼ 719), superior patient mortality (P ¼ .77,
n¼ 725), or lower postoperative complication rates (P¼ .67, n¼ 391).
 Cemented ﬁxation in THA has superior short-term clinical pain out-
comes (P ¼ .04, n ¼ 695).
Ni et al. [21] Systematic review
Femoral stems
 Cemented ﬁxation of femoral stems has better short-term clinical and
functional outcomes.
 For included RCTs, there is no difference in health-related quality of
life or heterotopic ossiﬁcation rates with respect to femoral stem
ﬁxation.
 Cementless ﬁxation of femoral stems demonstrated increased thigh
pain and reduced walking ability without support.
Hailer et al. [22] Swedish Registry Data
Primary THA
 Ten-year implant survival better for cemented THA (94%) than for
cementless THA (85%) (P < .0001).
 Stem revision due to periprosthetic fracture within 2 years 8 higher
for cementless femoral stems than for cemented femoral stems
(P < .001), most likely due to intraoperative femoral stems.
Eskelinen et al. [23] and
M€akel€a et al. [24]
Swedish Registry Data
Primary THA
 Ten-year implant survival better for with proximally and extendedly
porous-coated cementless femoral stems (91% and 89%) than with
uncoated cementless femoral stems (80%) or cemented femoral
stems (87%).
Engesaeter et al. [25] Norwegian Registry Data
Primary THA
 Cemented THA without antibiotic-impregnated cement is 1.8 times
more likely to be revised because of infection than cementless THA
(P ¼ .04).
Colas et al. [26] French Health Insurance Information System
Primary THA
 There was a signiﬁcant decrease in the risk of revision in cemented
THA with antibiotic-impregnated cement (2.4%, n ¼ 21,467) vs
cementless THA (3.3%, n ¼ 74,917; P < .001).
Eskelinen et al. [23] Finnish Registry Data
Primary THA
Younger patients (aged 55 years)
 Cementless femoral stems that are proximally circumferentially
porous-coated have a lower risk of aseptic loosening failure than
cemented femoral stems in younger patients (relative risk: 5.5,
P < .001).
 Cementless femoral stems were better for patients aged <55 years,
both for the risk of all revision (P < .002) and for the risk of
revisions due to aseptic loosening (P < .001)
J€amsen et al. [27] Finnish Registry
Older patients (aged 80 years)
 One-year survival, cementless femoral stems associated with 2.9
times higher rate of revision, especially in female patients.
M€akel€a et al. [24] Finnish Registry
Intermediate patients (aged 55-64 years)
 15-year survival is better in cementless straight femoral stems (91%)
vs cemented load-taper stems (77%; P < .001)
M€akel€a et al. [28] Swedish, Norwegian, Danish, and Finnish Registries
Intermediate patients (aged 55-64 years)
 15-year survival is not inﬂuenced by ﬁxation method: cemented
ﬁxation (84.1%) and cementless ﬁxation (82.8%).
Havelin et al. [29] Norwegian Registry
Patients aged <60 years
 Relative risk of revision for any reason with porous-coated
cementless femoral stems (2.5) compared to hydroxyapatite-coated
cementless femoral stems (1.0).
 Relative risk of revision for any reason with cemented femoral
stems (3.3) compared to hydroxyapatite-coated cementless
femoral stems (1.0).
M€akel€a et al. [30] Finnish Registry
Evolution of cementless femoral stems
 Survival-favored cemented stems from 1987 to 1996.
 No difference in survival from 1997 to 2006.
Strom et al. [31] Level I study
Femoral stem ﬁxation
 Fixation had no inﬂuence on radiographic stability.
 Cementless femoral stem group had radiolucent lines in 27% of cases
(6/23), cemented femoral stem group had no radiolucent lines (0/23).
Lindalen et al. [32] Level I Study
Femoral stem ﬁxation
Cemented femoral stems were collared
 Longer operating time in cemented ﬁxation group (85 min) than in
cementless ﬁxation group (77 min; P ¼ .05).
 Less blood loss in cemented ﬁxation group (674 mL) than in
cementless ﬁxation group (740 mL), not signiﬁcant (P ¼ .3)
Kim [33] Level I study
Bilateral THA comparison
 Cemented ﬁxation group has more radiolucent lines (9/70 ¼ 12.86%)
than the cementless ﬁxation group (3/70 ¼ 4.29%).
 Cementless ﬁxation group has a higher incidence of osteolysis
(9/70 ¼ 12.86%) than the cemented ﬁxation group (6/70 ¼ 8.57%).
 Cementless ﬁxation group has a higher incidence of calcar and
displaced fractures of the femur (3 each/70 ¼ 4.29%) than the
cemented ﬁxation group (0/70).
Emerson et al. [34] Level III
Femoral stem ﬁxation
 Cemented group has a higher incidence of femoral osteolysis (22/102¼
21.6%) than the cementless group (7/78 ¼ 8.97%; P ¼ .016).
 Cemented group had no revisions (0/102), whereas the cementless
group had 10 revisions (12.8%; 1 for femoral fracture and 9 for
aseptic loosening).
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the femoral stem is cemented and the acetabular cup is cement-
less. They found no signiﬁcant difference between cemented and
cementless ﬁxations when implant survival was measured by
revision rate (P ¼ .14, n ¼ 719) [20]. There was no difference in
patient mortality (P ¼ .77, n ¼ 725) or postoperative complication
rate (P ¼ .67, n ¼ 391) when comparing cemented and cementless
ﬁxations [20]. However, short-term clinical outcomes, particularly
pain, were improved with cemented ﬁxation (P ¼ .04, n ¼ 695)
[20]. The results for long-term clinical and functional outcomes
remain unclear based on the data available [20].
There is one systematic review with sufﬁcient details to draw
conclusions about ﬁxation techniques for femoral stems: Ni et al.
[21] performed a systematic review of literature comparing
cemented and cementless femoral stems; the results were further
subgrouped by study classiﬁcation: random controlled trial,
matched pairs, nonmatched pairs, and comparison in a single
patient (bilateral studies, one side cemented and one side
cementless). In general, short-term clinical and functional out-
comes are better with cemented femoral stems [21]. For the
random controlled trials, health-related quality of life and hetero-
topic ossiﬁcation rates were not different when comparing
cemented and cementless femoral stems, but the cementless group
demonstrated increased thigh pain and reduced walking ability
without support [21].
Results from meta-analyses/systematic reviews show that the
differences between cemented and cementless ﬁxations of primary
THA are limited; cemented ﬁxation has superior short-term clinical
and functional outcomes [20,21]. The usefulness for clinical appli-
cation is not clear.
Large population data
Conclusions about revision rates, and to some extent the causes
of revision, are possible by examining arthroplasty registry data
and large insurance databases; there are 11 articles in our review
that do so [22-30,35,36]. In addition, there are 3 recent registry
reports that contain similar data [37-39].
Hailer et al. [22] found in the Swedish Registry that 10-year
implant survival was better for cemented THA (94%) than for
cementless THA (85%); thiswasmainly due to the high rate of aseptic
loosening of cementless acetabular cups (P < .001). At 15-years,
implant survival continued to favor cemented THA (88%) over
cementless THA (70%). The risk of stem revision because of peri-
prosthetic fracturewithin 2 years of primary THAwas 8 times higher
for cementless femoral stems than for cemented femoral stems
(P < .001). The authors pointed out that unrecognized intraoperative
femoral fractures might be an important reason for early failure of
cementless femoral stems. Analysis of the Finnish Registry by other
researchers found that overall implant survival at 10 years was better
with proximally and extendedly porous-coated cementless femoral
stems (91% and 89%) than with uncoated cementless (80%) or
cemented stems (87%) [23,24]. None of these 3 studies focused on
speciﬁc implant designs although they did look at certain design
elements such as the extent and type of coating on cementless
femoral stems. In a different study, Engesaeter et al. [25] looked
speciﬁcally at the interaction of cement technique and the risk of
infection using data from the Norwegian Registry; cemented THA
without antibiotic-impregnated cement was 1.8 times more likely to
have revision because of infection than cementless THA (P ¼ .04).
There was no signiﬁcant difference between cemented THA with
antibiotic-impregnated cement and cementless THA (P ¼ .5) [24].
Colas et al. [26] used the French National Health Insurance Infor-
mation System to examine the differences in revision rates for THA,
comparing cementless ﬁxation, cemented ﬁxationwith and withoutantibiotic-impregnated cement, and hybrid ﬁxation. The data set
contained 100,191 patients aged at least 40 years who received their
THA between April 2010 and December 2011. There was a signiﬁcant
decrease in the risk of revision in cemented THA with antibiotic-
impregnated cement (2.4%, n ¼ 21,467) vs cementless THA (3.3%,
n ¼ 74,917; P < .001).
The remaining articles discuss revision rates for age groups by
comparing cemented and cementless ﬁxations. The consensus
across all national and 2 community registries is that older age and
cementless ﬁxation together increase the risk of revision
[23,24,27,28,35,36]. There is no absolute agreement on what con-
stitutes “older age”dsome registries deﬁne it as >65 years and
others as 75 years. J€amsen et al. [27] looked at patients in the
Finnish Registry who were of age 80 years at the time of THA.
They found that for these patients during the ﬁrst postoperative
year, cementless femoral stems are associated with a 2.9 times
higher rate of revision, especially female patients. The leading
cause of failure is periprosthetic fracture in the ﬁrst 12 months.
After that initial year, there is no signiﬁcant difference in survival
rates of cemented and cementless femoral stems; however, the
10-year survival for THA is slightly lower for cementless (93.9%)
than for cemented (97.4%) and hybrid (98.1%) constructs [27]. The
authors note that they were unable to identify failures that did not
result in revision surgery or intraoperative periprosthetic fractures
which were treated during the primary THA because of quality of
their data [27]. Examination of the Finnish Registry found that
modern cementless femoral stems, proximally circumferentially
porous coated, had a lower risk of aseptic loosening failure than
cemented femoral stems in younger patients of age <55 years
(relative risk: 5.5, P < .001) [23].
M€akel€a et al. have 2 articles looking at patients of intermediate
age (55-64 years old), one based on data solely from the Finnish
Registry and the other using data from 4 national registries:
Sweden, Norway, Denmark, and Finland [24,28]. In the study
looking at data from the Finnish registry (published in 2008), the
authors found that cementless femoral stems had a better 15-year
survival than cemented femoral stems (91% cementless straight
stems vs 77% cemented loaded-taper stems, P < .001) [24]. In the
more recent study (published in 2014), using data from 4 registries,
the ﬁxation method did not make a difference for 15-year survival
in patients 55-64 years of age (cemented ﬁxation: 84.1% and
cementless ﬁxation: 82.8%) [28].
Patients in the younger age group (typically, aged <55 years)
generally fare better with cementless femoral stems; however, date
of index THA has an impact in the revision risk [23,29,30]. Havelin
et al. [29] used the Norwegian Register and found that for patients
aged <60 years, cementless femoral stems with circumferential
porous coating, hydroxyapatite coating, or rough-blasted surface
have better survival rates than cemented femoral stems (P < .0001).
Eskelinen et al. [23] found that data in the Finnish Register showed
that cementless femoral stems were better for patients aged <55
years, both for the risk of all revision (P < .002) and for the risk of
revisions due to aseptic loosening (P < .001). The last article in this
group also used the Finnish Register; M€akel€a et al. [30] found that
the success of cementless femoral stems depended on when they
were implanted: from 1987 to 1996, survival was better for
cemented femoral stems and from 1997 to 2006, there was no
difference in the survival of cemented and cementless femoral
stems.
There are 3 recent national registry reports that provide results
regarding the causes of revision [37-39]. The ﬁrst, the Registro
dell'implantologia Protesica Ortopedica (Register of the Orthopae-
dic Prosthetic Implants), known as the RIPO Report from the
Emilia-Romagna region of Italy, reports the rates of revision for THA
from 2000 to 2013; the rate of revision for cementless THA was
Table 2
Rates of revision, as percent of failure cases for ﬁxation method, from 2000 to 2013,
RIPO 2013 Annual Report of Emilia-Romagna Region of Italy.
Fixation
method
Aseptic loosening
of femoral stem (%)
Recurrent
dislocation/subluxation (%)
Periprosthetic
fracture (%)
Cemented 11.7 16.0 6.8
Uncemented 15.6 16.8 12.4
Figure 2. Cumulative percent revision for 3 major registry reports. NJR, National Joint
Registry.
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stem, recurrent dislocation/subluxation, and periprosthetic frac-
ture (Table 2) [37]. The difference in revision rates for recurrent
dislocation and/or subluxation was very small (cementless: 16.8%
vs cemented: 16.0%); dislocation of THA is somewhat dependent on
surgical accuracy and may be less inﬂuenced by ﬁxation [40]. The
second, from the National Joint Registry of England, Wales and
Northern Ireland, found similar results; revision for aseptic loos-
ening, dislocation, and periprosthetic fracture was higher for
cementless THA (Table 3); again, the smallest difference was for
revision due to dislocation [38]. The Australian Orthopaedic Asso-
ciation (AOA) Registry Report found that cementless THA has a 2.2
times higher rate of revision in the ﬁrst month than cemented THA
[39]. The cumulative percent revision of primary THA is higher for
cementless constructs than for cemented or hybrid constructs
throughout the 11 years of data in the AOA Registry Report [39].
Both the RIPO and the National Joint Registry reports provide
limited information that allows comparison of risk of failure for
implant designs; the most popular constructs are the cementless
Corail femoral stem and Pinnacle acetabular cup (DePuy, Warsaw,
IN), the cemented Exeter femoral stem, and Contemporary
acetabular cup (Stryker, Kalamazoo, MI), and the hybrid construct
with the cemented Exeter femoral stem and the cementless Trident
cup (Stryker, Kalamazoo, MI). The AOA Registry Report, while
noting that the Exeter is the most common cemented implant and
the Corail is themost common cementless femoral stem, the details
surrounding the most common hybrid construct are not available.
The most common cemented femoral stem, whether in a totally
cemented construct or in a hybrid construct, was a highly-polished,
double-taper, and collarless stem. Interestingly, the failure rates for
hybrid constructs (cemented femoral stems and cementless
acetabular cups) were consistently lower than those for the totally
cemented and totally cementless constructs at 5 years and at 10
years (Fig. 2). Cementless THA has a higher cumulative revision rate
than other constructs with one exception, cemented THA at 10-
years in the RIPO Registry Report (Fig. 2).
Qualitative analysis of primary research
The qualitative analysis contains 5 articles that directly compare
cemented and cementless femoral stems: 4 are of level I quality
(RCTs) and one is of level III quality (retrospective controlled trials),
as described in by the Oxford Centre for Evidence-Based Medicine
[31-34,41,42]. The reason that this is a qualitative analysis rather
than a meta-analysis is due to 2 primary reasons: (1) lack ofTable 3
Revision rates, expressed as number per 1000 patient-years, from the National Joint
Registry of England, Wales and Northern Ireland.
Fixation method Aseptic
loosening
Dislocation/subluxation Periprosthetic
fracture
Cemented 0.96 (0.90-1.02) 0.88 (0.83-0.94) 0.33 (0.30-0.37)
Uncemented 1.92 (1.82-2.01) 1.20 (1.13-1.28) 0.81 (0.76-0.88)
The data are presented as % (95% CI).consistency when reporting outcomes and (2) absence of complete
sets of data, for example, sample size, mean, and standard devia-
tion. It should be noted that none of the femoral stem designs in
this section are collarless, polished, tapered designs such as those
detailed in the previous section.
The objective of Strom et al. [31], a level I study, was to compare
femoral stem ﬁxation in young patients of age <65 years. Two
femoral stem designs were used: the Cone stem was used in all
cementless cases (n ¼ 22) and the Bimetric (Biomet, Warsaw, IN)
grit-blasted femoral stem was used in all cemented cases (n ¼ 23).
All the femoral stems were radiographically stable, regardless of
cement ﬁxation. There were no radiolucent lines in the cemented
group but the cementless group had six (27%).
In a different level I study, Lindalen et al. [32] did not discuss
revisions; instead, they examined surgical variables and hip scores.
The cemented collared femoral stems were Spectron EF (Smith and
Nephew, London, UK; n ¼ 24), and the cementless stems were
Taperloc (Biomet, Warsaw, IN) (n ¼ 22). Both groups had im-
provements in Harris Hip Scores and Oxford Hip Scores at the
minimum 2-year follow-up, and there was no difference in the ﬁnal
scores. Operating time was slightly longer in the cemented femoral
stem group (85 minutes vs 77 for the cementless group, P ¼ .05);
however, blood loss was lower in the cemented stem group (674 vs
740 mL for the cementless group, P ¼ .3).
Kim [33] performed bilateral cemented and cementless THAs
on 70 patients aged <50 years (mean age, 39.9) and followed the
patients for a minimum of 6 years (mean follow-up, 7.8 years) in
this level I study. Cementless Proﬁle femoral stems (DePuy, Leeds,
UK) were used in 70 hips, and the contralateral side was
implanted with Cemented Elite Plus femoral stems; neither of
these are collarless nor smooth (DePuy, Leeds, UK). There were
no incidents of transitory thigh pain at last follow-up, and there
were no reoperations due to aseptic loosening in either group.
The cemented group had more radiolucent lines (n ¼ 9, 12.86%)
than the cementless group (n ¼ 3, 4.29%), but the cementless
group had a higher incidence of osteolysis (n ¼ 9, 12.86%) than
the cemented group (n ¼ 6, 8.57%). Each group experienced 3
dislocations after surgery, but fractures of the calcar and dis-
placed fractures of the femur were only reported in the
cementless group (3 each, 4.29%).
In a level III study with a minimum 2-year follow-up, Emerson
et al. [34] followed 102 cemented and collared stems (Mallory-
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stems (Mallory-Head circumferential porous coated; Biomet,
Warsaw, IN). There were no trochanteric fractures and no revisions
due to infection in either group. There was a higher incidence of
femoral osteolysis in the cemented group (n ¼ 22, 21.6%) than with
the femoral implant used in the cementless group (n ¼ 7, 8.97%;
P ¼ .016). The cementless group experienced no revisions, whereas
the cemented group had a single revision for femoral fracture and 9
revisions for aseptic loosening. The survivorship of the cementless
group was 100% and 84% for the cemented group at 10-year
follow-up.
Discussion
The results of our systematic review do not provide conclusive
evidence that one form of femoral stem ﬁxation is demonstratively
better for all patients. However, when stratiﬁed by age, older
patients with cementless ﬁxation demonstrate an increased risk of
revision [19,22,24,26-28,35,36]. Taking into account revision rates
in midaged patients, 55-64 years, our results do not present a clear
advantage for either mode of ﬁxation [24,28]. Younger patients,
aged <55 years typically, fare better in terms of revision rates with
cementless ﬁxation [19,23,29,30]. Short-term outcomes such as
pain and independent walking ability are improved with cemented
ﬁxation [20,21]. Multiple sources agree that cementless ﬁxation
increases the risk of periprosthetic fracture [22,37-39,43-45].
However, the risk of revision due to aseptic loosening does not
demonstrate dominance for either ﬁxation method [23,24,37-39].
The direct cost of primary THA is made up of many factors
including implant costs, hospital costs, and professional fees. After
primary THA, there are often secondary costs associated with com-
plications, readmissions, infections, reoperations, and revisions.
Some of these are not too difﬁcult to calculate, but the impact on
patient welfare, their families, and their caregivers is difﬁcult to
quantify.
The direct costs of primary THA are somewhat easier to calcu-
late. The 8th Annual National Joint Registry Report found that the
cost of a primary cemented femoral component plus the associated
cement and accessories is £820 per THA, whereas the cost of a
primary cementless femoral component was £915 per THA [46,47].
Similar data from the United States agree that cementless femoral
prostheses are consistentlymore expensive than cemented femoral
prostheses evenwhen including the cost of cement plus accessories
[14]. The indirect primary costs such as quality of life and patient
satisfaction should be combined with the direct primary THA costs
to fully determine value. A further study of the costs and quality of
life for THA looked at data from the National Health Service of
England and found that cemented THA has the lowest lifetime
costs, hybrid THA has the highest quality of life and the highest
quality-adjusted life yearsmaking it themost cost-effective ﬁxation
option, and cementless THA does not provide sufﬁcient improve-
ment to justify the higher cost [48].
The overall cost of revision THA such as treating complications,
readmissions, the associated morbidity and mortality, and the
impact on patient welfare and satisfaction are all part of the value
equation. According to data from the 8th Annual National Joint
Registry Report, there was an annual increase of 9.8% for revision
THA and the costs to the National Health System was £1.5B and are
expected to rise [15,47]. M€ardian et al. [12] focused on one compli-
cation, periprosthetic fracture, and the implications to patient wel-
fare and mortality. Elderly patients, in particular, often have a
perceptible decline in function compared to the normal population,
remarkably high complication rates (25.4%) after postoperative
periprosthetic fracture; many of these patients do not recover pre-
operative ambulatory status. Periprosthetic fracture was found morefrequently in cementless THA than in cemented THA. Most surpris-
ingly, within 3 years of periprosthetic fractures, over 50% of patients
have died [12].
The implications of a growing demand for THA coupled with a
possible increased incidence of early complications and reopera-
tions are likely to have an increasing adverse effect on the economic
sustainability of the current health care system. All of these are now
being closely monitored and reported, and soon will be directly
linked to reimbursement and compensation, and most likely have
an impact on public health care services [9].
The early complications from cementless femoral stems are
clear; ﬁbrous ingrowth, aseptic loosening, thigh pain, leg length
discrepancy, and periprosthetic fracture contribute to the likeli-
hood of secondary or revision surgery [2-7,49,50]. These early
complications have been shown to occur at lower rates with
cemented femoral stems in most populations [2-7,49,50]. With
these secondary reoperations, there is an increase in the risk for
dislocation, wound difﬁculties, infection and an overall increase in
costly health care needs as well as increases in morbidity and
mortality. The cost relative to human pain and to risks inherent
with repeated surgery is not to be ignored. We should be “getting it
right ﬁrst time” by using the most reliable implants with proven
survivorship to contain costs and complications [15].
There is limited information concerning the impact of femoral
stem design features [16,27,51,52]. Highly-polished, tapered,
collarless cemented stems work well because they are very
forgiving in practice and it is easier to achieve accurate leg length,
anteversion, and neck offset [16]. The Exeter femoral stem is a
highly-polished, collarless, double-taper design that has been in
use for many years. There is an indication of “settling-in” from
J€amsen et al. [27]; the unadjusted survival of Exeter stems has a
weak tendency to be less steep after 4 or 5 months after primary
THA. Howie et al. [51] found that the cemented Exeter stem has
very good long-term survivorship in young patients: survivorship
for loosening at 13 years is 100% and survivorship for all reasons at
13 years is 97% (95% CI: 93%-100%). Ling et al. [52] looked at the
original Exeter stem; they found excellent long-term survivorship
(over 30 years) for aseptic loosening although old cementing
techniques were used (93.5%, 95% CI: 90.0%-97.0%).
The most important limitation of this systematic review is the
lack of congruency of available data such as revisions, reasons for
revisions, survivorship analysis, complications, and clinical and
functional outcomes. The lack of standardized methods of
reporting outcomes, even among the various national and inter-
national joint registries, makes it rather complex to make com-
parisons, and thus, creating evidence-based conclusions can be
difﬁcult. However, this condition is not limited to this systematic
review; these difﬁculties exist throughout a majority of medical
literature.
The second limitation is the difﬁculty in determining implant
and ﬁxation utilization. It is common to discover a good, thorough
article but the utilization is “unclear”; there may be a variety of
implants used, but the results are comingled so that the effect of
implant design cannot be determined or delineated.
A possible third limitation, or perhaps something to consider
when looking at registry data, is that cementless ﬁxation of femoral
stems is a much younger data set than cemented ﬁxation; thus,
there is the possibility that the newer technique is inﬂuenced by a
shorter evolution of practice.
This literature summary has made an effort to extrapolate as
much data as possible from as many sources as possible, and other
meta-analyses/systematic reviews, clinical and safety studies of all
levels of evidence, and registry reports were scrutinized in efforts
to determine what the evidence currently reveals about the use of
cemented and cementless femoral stems.
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Using evidenced-based data, in conjunction with information
provided by joint registries, should help provide better guidance on
selecting the most reliable implants with proven survivorship
lowering early postoperative complications, readmissions, reoper-
ation and revision burdens, and health care costs, along with
improving patient satisfaction and overall outcomes especially in
the growing elderly populations, osteoporotic and at-risk subgroup
of patients with poor bone quality undergoing THA. The authors
feel that despite the apparent observation that cementless femoral
ﬁxation for THA has evolved as the accepted “new standard,” it still
has not been proven to be the “gold standard” for all patients.
Revisiting the use of contemporary cement techniques, in
conjunction with proven femoral implant designs that have
excellent evidenced-based survivorship, warrants strong consid-
eration for several subgroups of patients undergoing elective THA,
thus increasing the likelihood of “getting it right the ﬁrst time” and
decreasing the incidence of early complications and associated
morbidity and mortality of reoperations.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.artd.2016.02.001
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